Medical Expenditures Associated With Hypertension in the U.S., 2000–2013

Details

• Alternative Title:
  Am J Prev Med
• Personal Author:
  Zhang, Donglan ; Wang, Guijing ; Zhang, Ping ; Fang, Jing ; Ayala, Carma
• Description:
  Introduction
  
  Trends of prevalence, treatment, and control of hypertension have been documented in the U.S., but changes in medical expenditures associated with hypertension over time have not been evaluated. This study analyzed these expenditures during 2000–2013 among U.S. adults.
  
  Methods
  
  Data from the Medical Expenditure Panel Survey were analyzed in 2016. The study population was non-institutionalized men and non-pregnant women aged ≥18 years. Hypertension was defined as ever been diagnosed with hypertension or currently taking antihypertensive medications. Medical expenditures included all payments to medical care providers. Expenditures associated with hypertension were estimated by two-part regression models and adjusted into 2015 U.S. dollars. Controlling variables included sociodemographic characteristics, marital status, insurance, region, smoking status, weight status, health status, and comorbidities. Trends were analyzed using joinpoint method.
  
  Results
  
  Total per-person annual expenditures associated with hypertension in 2000–2001 ($1,399) were not significantly different from those in 2012–2013 ($1,494) (average annual percent change [AAPC]= −0.6%, p=0.794), but annual national spending increased significantly from $58.7 billion to $109.1 billion (AAPC=8.3%, p=0.015), mainly because of the increase in the number of people treated for hypertension. Per-person outpatient payments were 22.7% higher in 2012–2013 than in 2000–2001 ($416 vs $322, p<0.05; AAPC=0.8%, p-trend 0.826). Payments for prescription medications took up a larger proportion of the medical expenditures associated with hypertension, compared to payments for outpatient or other services (33%–46%).
  
  Conclusions
  
  During 2000–2013, annual national medical expenditures associated with hypertension increased significantly. Preventing hypertension could alleviate hypertension-associated economic burden.
  
  
• Subjects:
  Adult Aged Ambulatory Care Antihypertensive Agents Comorbidity Cost Of Illness Female Health Expenditures Health Status Humans Hypertension Insurance, Health Male Middle Aged Prescription Drugs Prevalence United States Young Adult

  More +
• Source:
  Am J Prev Med. 53(6 Suppl 2):S164-S171
• Pubmed ID:
  29153117
• Pubmed Central ID:
  PMC5823517
• Document Type:
  Journal Article
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/ ; U36 OE000005/OE/OSELS CDC HHSUnited States/
• Volume:
  53
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:1847013809a011f8a9fafdb4034d5d3954e2f1c79791d90248be5fe316b6acb1
• Download URL:
  https://stacks.cdc.gov/view/cdc/52068/cdc_52068_DS1.pdf
• File Type:
  [PDF - 98.50 KB ]